The FDA has authorized its first COVID-19 diagnostic for the purpose of broad-based screening. This would include people who haven’t shown any symptoms and those who don’t suspect having come in contact with someone suffering from COVID-19.
CMS releases Medicare payment rates for CPT codes for COVID-19 tests
CMS released the payments rates for new Current Procedural Terminology (CPT) codes, which is developed by the American Medical Association (AMA) for COVID-19 diagnostic tests.
Upto $250B of healthcare spending could shift to virtual: McKinsey report
More patients and providers are being exposed to telehealth and virtual care. In such a scenario, a report was published by McKinsey predicting that $250 billion of current U.S. healthcare spending could be virtualized.